WST
WEST PHARMACEUTICAL SERVICES INC
NYSE · Healthcare · Medical - Instruments & Supplies · US
$362.16
−1.21%Next report
Analyst consensus
- Next report date
- Oct 22, 2026
- EPS estimate
- $2.18
- Revenue estimate
- $829.9M
Latest reported
- Last report date
- Jul 23, 2026
- EPS actual
- $2.37
- EPS estimate
- $2.08
- Revenue actual
- $872.3M
- Revenue estimate
- $840.6M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 11
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +17.1%
- Revenue beats (12Q)
- 8
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $409
- PT range
- $365 – $447
- Analysts
- 7
6 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 23, 2026 | $2.08 | $2.37 | Beat 13.78% | $872.3M |
| Apr 23, 2026 | $1.68 | $2.13 | Beat 26.94% | $844.9M |
| Feb 12, 2026 | $1.83 | $2.04 | Beat 11.41% | $805.0M |
| Oct 23, 2025 | $1.68 | $1.96 | Beat 16.46% | $804.3M |
| Jul 24, 2025 | $1.51 | $1.84 | Beat 22.18% | $766.2M |
| Apr 24, 2025 | $1.22 | $1.45 | Beat 18.66% | $698.0M |
| Feb 13, 2025 | $1.71 | $1.82 | Beat 6.62% | $748.8M |
| Oct 24, 2024 | $1.51 | $1.85 | Beat 22.60% | $746.9M |
| Jul 25, 2024 | $1.74 | $1.52 | Miss -12.84% | $702.0M |
| Apr 25, 2024 | $1.27 | $1.56 | Beat 22.64% | $695.4M |
| Feb 15, 2024 | $1.78 | $1.83 | Beat 2.98% | $732.0M |
| Oct 26, 2023 | $1.86 | $2.16 | Beat 16.19% | $747.4M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 22, 2026